Signed in as:
filler@godaddy.com
Nanomedicine explained from first principles through to clinical practice, written by Prof. Dr. Tamer Biomi, R.Ph., M.S., Ph.D., Chief Scientific Officer at NanoMed Solution.
Four series run here, each serving a different purpose. Browse any of them below, or use the category tabs further down the page.

A ten-part series on what the nanoscale is, why materials behave differently there, and how that science became medicine.
Each post assumes only what the ones before it covered, so start at the top:
Principal nanoformulation designs and the criteria behind them, their defining characteristics, CMC considerations, and the outcomes typically achieved. Written for pharmaceutical scientists and product developers.
A working reference on the materials themselves: lipid and phospholipid libraries, biopolymers and hydrogels, hybrid molecules, and excipients. What each one offers, the properties that distinguish it, and the technical advantages it brings to a nanoformulation.
Commentary on approvals, trial results, regulatory developments and debates shaping the field.
Richard Feynman, Ph.D. (Nobel Laureate) 12/29/1965

Copyright © 2023 NanoMed Solution - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be anonymously aggregated with all other user data.